Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGOV
1376
DELISTED
NIC Inc
EGOV
| $3.43M | ﹤0.01% |
149,500
+19,600
| +15% | +$464K |
|
1377
Ambarella
AMBA
$3.6B
| $3.43M | ﹤0.01% |
74,833
+17,100
| +30% | +$881K |
|
1378
Akebia Therapeutics
AKBA
$241M
| $3.43M | ﹤0.01% |
252,285
+102,300
| +68% | +$1.06M |
|
|
BEAT
1379
DELISTED
BioTelemetry, Inc.
BEAT
| $3.42M | ﹤0.01% |
75,800
+9,900
| +15% | +$444K |
|
1380
TG Therapeutics
TGTX
$7.34B
| $3.42M | ﹤0.01% |
175,700
+1,900
| +1% | +$30.6K |
|
|
ALTR
1381
DELISTED
Altair Engineering Inc
ALTR
| $3.41M | ﹤0.01% |
85,800
+15,200
| +22% | +$517K |
|
1382
First Merchants
FRME
$2.72B
| $3.41M | ﹤0.01% |
123,662
+15,600
| +14% | +$417K |
|
1383
HUTCHMED
HCM
$2.13B
| $3.39M | ﹤0.01% |
122,787
| – | – |
|
1384
Horace Mann Educators
HMN
$2.09B
| $3.38M | ﹤0.01% |
92,100
+12,200
| +15% | +$429K |
|
|
CXP
1385
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $3.38M | ﹤0.01% |
257,245
+30,500
| +13% | +$402K |
|
|
TWNK
1386
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $3.36M | ﹤0.01% |
274,900
+40,300
| +17% | +$477K |
|
|
CUB
1387
DELISTED
Cubic Corporation
CUB
| $3.36M | ﹤0.01% |
69,900
+12,300
| +21% | +$500K |
|
|
LTC
1388
LTC Properties
LTC
$2.1B
| $3.34M | ﹤0.01% |
88,762
+11,700
| +15% | +$417K |
|
1389
Glaukos
GKOS
$11.2B
| $3.34M | ﹤0.01% |
87,000
+11,400
| +15% | +$424K |
|
1390
Asbury Automotive
ABG
$3.76B
| $3.34M | ﹤0.01% |
43,200
+5,700
| +15% | +$383K |
|
1391
Global Net Lease
GNL
$1.9B
| $3.34M | ﹤0.01% |
199,667
+26,200
| +15% | +$375K |
|
1392
Comfort Systems
FIX
$60.8B
| $3.33M | ﹤0.01% |
81,800
+10,700
| +15% | +$380K |
|
1393
Walker & Dunlop
WD
$1.45B
| $3.33M | ﹤0.01% |
65,600
+8,800
| +15% | +$360K |
|
1394
Graham Holdings Company
GHC
$5.03B
| $3.32M | ﹤0.01% |
9,700
+1,300
| +15% | +$457K |
|
1395
Cerence
CRNC
$389M
| $3.32M | ﹤0.01% |
81,350
+10,800
| +15% | +$310K |
|
1396
Trustmark
TRMK
$2.79B
| $3.32M | ﹤0.01% |
135,300
+16,900
| +14% | +$407K |
|
1397
Antero Midstream
AM
$10.5B
| $3.31M | ﹤0.01% |
648,400
+209,100
| +48% | +$925K |
|
1398
Belden
BDC
$5.39B
| $3.3M | ﹤0.01% |
101,500
+13,400
| +15% | +$446K |
|
1399
Capitol Federal Financial
CFFN
$1.1B
| $3.3M | ﹤0.01% |
300,100
+39,500
| +15% | +$453K |
|
|
IBTX
1400
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.3M | ﹤0.01% |
81,522
+14,900
| +22% | +$482K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.